JACKLYN BURKEY: Open Payments
NPI 1023846961 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 40 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $157 |
| Alkermes, Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Amgen Inc. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $49 |
| Lilly USA, LLC | 3 | $48 |
| Lundbeck LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: FANAPT, REXULTI, LYBALVI, Auvelity, OTEZLA, Kerendia, Rybelsus, MOUNJARO.
Industry payments across MI — which companies pay providers there.
